BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension-Reference-Cited by-同舟云学术

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension

Published:2005 Issue:2 Volume:26 Page:119-124
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

Sankelo Marja,Flanagan Julia A,Machado Rajiv,Harrison Rachel,Rudarakanchana Nung,Morrell Nicholas,Dixon Morag,Halme Maija,Puolijoki Hannu,Kere Juha,Elomaa Outi,Kupari Markku,Räisänen-Sokolowski Anne,Trembath Richard C.,Laitinen Tarja

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference22 articles.

1. Primary Pulmonary Hypertension In Israel

2. Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

3. Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin

4. Evidence of Founder Mutations in Finnish BRCA1 and BRCA2 Families

5. Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-β Receptor

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan;Frontiers in Cardiovascular Medicine;2022-06-22

2. Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study;Pulmonary Circulation;2022-01

3. Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension;American Journal of Respiratory and Critical Care Medicine;2020-06-01

4. Molecular genetic framework underlying pulmonary arterial hypertension;Nature Reviews Cardiology;2019-08-12

5. Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy;Cytokine & Growth Factor Reviews;2019-06